Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 65 entries
View as:

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00803647 Org: User:
Start: 01/31/10 End: 11/30/14 Due: 11/30/15

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Phase: N/A Priority: Normal
NCT ID: NCT00004067 Org: User:
Start: 02/29/00 End: 11/30/19 Due: 11/30/20

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00110695 Org: User:
Start: 04/30/05 End: 07/31/08 Due: 07/31/09

Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00427310 Org: User:
Start: 03/31/84 End: 02/28/01 Due: 02/28/02

Tamoxifen Study

Phase: N/A Priority: Normal
NCT ID: NCT00000529 Org: User:
Start: 05/31/92 End: 11/30/95 Due: 11/30/96

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00887536 Org: User:
Start: 05/31/09 End: 02/28/18 Due: 02/28/19

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Phase: N/A Priority: Normal
NCT ID: NCT03457896 Org: User:
Start: 05/18/18 End: 09/30/22 Due: 09/30/23

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002967 Org: User:
Start: 05/31/97 End: 03/31/06 Due: 03/31/07

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00365417 Org: User:
Start: 08/31/06 End: 11/30/09 Due: 11/30/10

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00093795 Org: User:
Start: 10/31/04 End: 06/30/16 Due: 06/30/17

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05178576 Org: User:
Start: 06/24/22 End: 02/28/27 Due: 02/28/28

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01547741 Org: User:
Start: 04/30/12 End: 11/30/23 Due: 11/30/24

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01011478 Org: User:
Start: 03/31/10 End: 02/28/15 Due: 02/28/16

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01423123 Org: User:
Start: 05/31/11 End: 03/31/14 Due: 03/31/15

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01960023 Org: User:
Start: 10/31/13 End: 07/13/16 Due: 07/13/17

Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00425152 Org: User:
Start: 07/31/89 End: 04/30/04 Due: 04/30/05

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT00016432 Org: User:
Start: 05/31/01 End: 02/28/11 Due: 02/28/12

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00378716 Org: User:
Start: 02/28/97 End: 04/30/09 Due: 04/30/10

NSABP Patient Registry and Biospecimen Profiling Repository

Phase: N/A Priority: Normal
NCT ID: NCT01793805 Org: User:
Start: 02/28/13 End: 03/31/22 Due: 03/31/23

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02664077 Org: User:
Start: 06/30/16 End: 10/31/19 Due: 10/31/20

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00058474 Org: User:
Start: 07/31/04 End: 05/31/16 Due: 05/31/17

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003830 Org: User:
Start: 05/31/99 End: 02/28/14 Due: 02/28/15

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01872975 Org: User:
Start: 08/31/13 End: 08/31/28 Due: 08/31/29

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00087178 Org: User:
Start: 05/31/04 End: 05/31/16 Due: 05/31/17

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03628066 Org: User:
Start: 10/22/18 End: 01/30/21 Due: 01/30/22